Long-Term Percutaneous Coronary Intervention Rates and Associated Independent Predictors for Progression of Nonintervened Nonculprit Coronary Lesions

American Journal of Cardiology

Volumn 104, Issue 5, 2009, Pages 648-652

  Park, Mahn Won ^a   Seung, Ki Bae ^a   Kim, Pum Joon ^a   Park, Hun Jun ^a   Yoon, Sung Gyu ^a   Baek, Joo Yeoul ^a   Koh, Yoon Seok ^a   Jung, Hae Ok ^a   Chang, Kiyuk ^a   Kim, Hee Yeoul ^a   Baek, Sang Hong ^a  

^a Dongguk University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; CLINICAL FEATURE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE COURSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; COMORBIDITY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY STENOSIS; DISEASE PROGRESSION; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; LOGISTIC MODELS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TRIGLYCERIDES;

EID: 68749119560     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.04.052     Document Type: Article

References (22)

1. Zairis M.N., Ambrose J.A., Manousakis S.J., Stefanidis A.S., Papadaki O.A., Bilianou H.I., DeVoe M.C., Fakiolas C.N., Pissimissis E.G., Olympios C.D., Foussas S.G., and The GENERATION Study Group. The impact of plasma levels of C-reactive protein, lipoprotein(a) and homocystein on the long-term prognosis after successful coronary stenting. J Am Coll Cardiol 40 (2002) 1375-1382
2. Glaser R., Selzer F., Faxon D.P., Lakey W.K., Cohen H.A., Slater J., Detre K.M., and Wilensky R.L. Clinical progression of incidental, asymptomatic lesions discovered during culprit vessel coronary intervention. Circulation 111 (2005) 143-149
3. Kaski J.C., Chen L., and Chester M.R. Rapid angiographic progression of "target" and "nontarget" stenoses in patients awaiting coronary angioplasty. J Am Coll Cardiol 26 (1995) 416-421
4. Lichtlen P.R., Nikutta P., Jost S., Deckers J., Wiese B., and Rafflendbeul W. Anatomical progression of coronary artery disease in humans as seen by prospective, repeated quantitated coronary angiography. Circulation 86 (1992) 828-838
5. Criqui M.H., Heiss G., Cohn R., Cowan L.D., Suchindran C.M., Bangdiwala S., Kritchevsky S., Jacobs Jr. R., D'Grady H.K., and David C.E. Plasma triglyceride level and mortality from coronary heart disease. N Engl J Med 328 (1993) 1220-1225
6. Pocock S.J., Shaper A.G., and Phillips A.N. Concentrations of high-density lipoprotein cholesterol, triglycerides, and total cholesterol in ischemic heart disease. BMJ 298 (1989) 998-1002
7. Asia Pacific Cohort Studies Collaboration. Serum triglycerides as a risk factor for cardiovascular disease in the Asia-Pacific region. Circulation 110 (2004) 2678-2686
8. Ninomiya J.K., L'Italien G., Criqui M.H., Whyte J.L., Gamst A., and Chen R.S. Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey. Circulation 109 (2004) 42-46
9. Abdel-Maksoud M.F., and Hokanson J.E. The complex role of triglycerides in cardiovascular disease. Semin Vasc Med 2 (2002) 325
10. Castelli W.P. Epidemiology of triglycerides: a view form Framingham. Am J Cardiol 70 suppl (1992) 3H-9H
11. Burchfiel C.M., Laws A., Benfante R., Goldberg R.J., Hwang L.J., Chiu D., Rodriguez B.L., Curb D., and Sharp D.S. Combined effects of HDL cholesterol, triglyceride, and total cholesterol concentration on 18-year risk of atherosclerotic disease. Circulation 92 (1995) 1430-1436
12. Jeppensen J., Jein H.O., Suadicani P., and Gyntelberg F. Relation of high TG-low HDL cholesterol and LDL cholesterol to the incidence of ischemic heart disease. An 8-year follow-up in the Copenhagen Male Study. Arterioscler Thromb Vasc Biol 17 (1997) 1114-1120
13. Torzewski M., Reifenberg K., Cheng F., Wiese E., Küpper I., Crain J., Lackner K.J., and Bhakdi S. No effect of C-reactive protein on early atherosclerosis in LDLR-/-/human C-reactive protein transgenic mice. Thromb Haemost 99 (2008) 196-201
14. Singh S.K., Suresh M.V., Voleti B., and Agrawal A. The connection between C-reactive protein and atherosclerosis. Ann Med 40 (2008) 110-120
15. Kovacs A., Tornvall P., Nilsson R., Tengér J., Hamsten A., and Björkegren J. Human C-reactive protein slows atherosclerosis development in a mouse model with human-like hypercholesterolemia. Proc Natl Acad Sci U S A 104 (2007) 13768-13773
16. Zouridakis E., Avanzas P., Espliguero R.A., Fredericks S., and Kaski J.C. Markers of inflammation and rapid coronary artery disease progression in patients with stable angina pectoris. Circulation 110 (2004) 1747-1753
17. Liang K.W., Sheu W.H., Lee W.L., Liu T.J., Ting C.T., Chen Y.T., and Lee W.J. Coronary artery disease progression is associated with C-reactive protein and conventional risk factors but not soluble CD40 ligand. Can J Cardiol 22 (2006) 691-696
18. Nakachi T., Kosuge M., Hibi K., Ebina T., Hashiba K., Mitsuhashi T., Endo M., Umemura S., and Kimura K. C-reactive protein elevation and rapid angiographic progression of nonculprit lesion in patients with non-ST segment elevation acute coronary syndrome. Circ J 72 (2008) 1953-1959
19. Tornvall P., Hamsten A., Hansson L.O., O'Konor M.L., Ericsson C.G., Strandberg L.E., Boavida A., and Bergstrand L. Plasma C-reactive protein and lipoprotein levels, and progression of coronary artery disease after myocardial infarction treated with thrombolysis. Cardiology 104 (2005) 65-71
20. Saleh N., and Tornvall P. Serum C-reactive protein response to percutaneous coronary intervention in patients with unstable or stable angina pectoris is associated with the risk of clinical restenosis. Atherosclerosis 195 (2007) 374-378
21. Albert M.A., and Ridker P.M. C-reactive protein as a risk predictor: do race/ethnicity and gender make a difference?. Circulation 114 (2006) e67-e74
22. Arima H., Kubo M., Yonemoto K., Doi Y., Ninomiya T., Tanizaki Y., Hata J., Matsumura K., Iida M., and Kiyohara Y. High-sensitivity C-reactive protein and coronary heart disease in a general population of Japanese: the Hisayama study. Arterioscler Thromb Vasc Biol 28 (2008) 1222-1224